In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Grunenthal to sell Labopharm's pain drug in France

Executive Summary

Specialty pharma Labopharm licensed Grunenthal (develops and markets pain treatments) semi-exclusive French marketing rights to its once-daily centrally acting analgesic tramadol. Grunenthal shares rights with Sanofi-Aventis in this territory.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
Deal Status
  • Final
Deal Type
  • Alliance
    • Marketing-Licensing

Related Companies